Cronos Group Inc. (CRON)
NASDAQ: CRON · IEX Real-Time Price · USD
2.380
+0.030 (1.28%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Cronos Group Revenue
Cronos Group had revenue of $93.03M in the twelve months ending March 31, 2024, with 11.37% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $25.29M with 29.72% year-over-year growth. In the year 2023, Cronos Group had annual revenue of $87.24M with 0.57% growth.
Revenue (ttm)
$93.03M
Revenue Growth
+11.37%
P/S Ratio
9.77
Revenue / Employee
$261,331
Employees
356
Market Cap
909.19M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 87.24M | 492.00K | 0.57% |
Dec 31, 2022 | 86.75M | 22.19M | 34.37% |
Dec 31, 2021 | 64.56M | 17.84M | 38.19% |
Dec 31, 2020 | 46.72M | 22.97M | 96.71% |
Dec 31, 2019 | 23.75M | 11.63M | 95.94% |
Dec 31, 2018 | 12.12M | 8.97M | 285.16% |
Dec 31, 2017 | 3.15M | 2.72M | 638.69% |
Dec 31, 2016 | 426.03K | - | - |
Dec 31, 2015 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Pacira BioSciences | 681.75M |
HealthStream | 282.88M |
CareDx | 275.11M |
Harrow Health | 138.68M |
AbCellera Biologics | 35.79M |
AnaptysBio | 22.96M |
Viridian Therapeutics | 288.00K |
Perspective Therapeutics | -304.00K |
CRON News
- 13 days ago - The Best Marijuana Stocks This Week - MarijuanaStocks
- 16 days ago - Cronos Group Inc. to Reconvene Virtual 2024 Annual Meeting of Shareholders - GlobeNewsWire
- 25 days ago - Cronos Brand Spinach® Celebrates Summer with New Launches - GlobeNewsWire
- 4 weeks ago - Cronos Group Inc. Announces Results of 2024 Annual Meeting of Shareholders - GlobeNewsWire
- 4 weeks ago - Legal cannabis sales eat into beer revenue, survey data shows - Market Watch
- 4 weeks ago - Cronos Group Announces Expansion of GrowCo to Fuel Global Growth - GlobeNewsWire
- 4 weeks ago - June 2024: Canadian Cannabis Stocks with High Potential - MarijuanaStocks
- 4 weeks ago - Tim Seymour On Running A Cannabis Fund: 'We Focus On Companies Poised For Growth' - Benzinga